PLx Pharma Winddown Corp.

OTCPK:PLXP.Q Rapporto sulle azioni

Cap. di mercato: US$30.0

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

PLx Pharma Winddown Gestione

Gestione criteri di controllo 1/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Pat Lonergan

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEOno data
Proprietà del CEOn/a
Durata media del managementNessun dato
Durata media del Consiglio di amministrazione5.8yrs

Aggiornamenti recenti sulla gestione

Recent updates

PLx Pharma Non-GAAP EPS of -$0.52 misses by $0.02, revenue of $0.48M

Aug 12

Is PLx Pharma (NASDAQ:PLXP) In A Good Position To Deliver On Growth Plans?

May 10
Is PLx Pharma (NASDAQ:PLXP) In A Good Position To Deliver On Growth Plans?

Most Shareholders Will Probably Find That The CEO Compensation For PLx Pharma Inc. (NASDAQ:PLXP) Is Reasonable

Nov 03
Most Shareholders Will Probably Find That The CEO Compensation For PLx Pharma Inc. (NASDAQ:PLXP) Is Reasonable

We're Interested To See How PLx Pharma (NASDAQ:PLXP) Uses Its Cash Hoard To Grow

Sep 23
We're Interested To See How PLx Pharma (NASDAQ:PLXP) Uses Its Cash Hoard To Grow

PLx Pharma: First Commercial Launch Makes It Attractive

Sep 17

PLx Pharma (NASDAQ:PLXP) Is In A Strong Position To Grow Its Business

Jun 15
PLx Pharma (NASDAQ:PLXP) Is In A Strong Position To Grow Its Business

Have Insiders Been Buying PLx Pharma Inc. (NASDAQ:PLXP) Shares?

Mar 05
Have Insiders Been Buying PLx Pharma Inc. (NASDAQ:PLXP) Shares?

PLx Pharma EPS misses by $0.10

Nov 16

AMMINISTRATORE DELEGATO

Pat Lonergan (88 yo)

no data

Mandato

Mr. Patrick M. Lonergan, also known as Pat, co-founded Numark Laboratories Inc. in 1987 and has been its President since January 1989. Mr. Lonergan serves as Member of Chief Executive Officer Advisory Grou...

Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Michael Valentino
Chairman12.3yrsUS$393.75k1.62%
$ 0.5
Kirk Calhoun
Independent Director8yrsUS$55.00k0.0055%
$ 0.002
Todd Rosengart
Member of Scientific Advisory Board5.8yrsNessun datoNessun dato
Robert Casale
Independent Director7.7yrsUS$75.50k0.0089%
$ 0.003
Gary Balkema
Independent Director7.7yrsUS$50.00k0.018%
$ 0.005
P. Steg
Member of Scientific Advisory Board5.8yrsNessun datoNessun dato
Deepak Bhatt
Member of Scientific Advisory Board5.8yrsNessun datoNessun dato
Byron Cryer
Member of Scientific Advisory Board5.8yrsNessun datoNessun dato
Jayne Prats
Member of Scientific Advisory Board5.8yrsNessun datoNessun dato
Efthymios Deliargyris
Member of Scientific Advisory Board3.5yrsUS$801.65kNessun dato
Dominick Angiolillo
Member of Scientific Advisory Board5.8yrsNessun datoNessun dato
Carey Kimmelstiel
Member of Scientific Advisory Board5.8yrsNessun datoNessun dato

5.8yrs

Durata media

66.5yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di PLXP.Q sono considerati esperti (durata media dell'incarico 5.8 anni).